文献速递消化内镜消化道肿瘤与早癌

WASh多中心随机对照试验:英国NHS肠镜筛查中注水辅助乙状结肠镜检查

WASh multicentre randomised controlled trial: water-assisted sigmoidoscopy in English NHS bowel scope screening.
PubMed 文献 · Gut · 2020-09-07

WASh试验为多中心单盲随机对照试验,将1123名接受英国肠道筛查项目乙状结肠镜检查的55岁受试者随机分入注水辅助乙状结肠镜(WAS)组或标准CO2组,发现两组患者报告的轻中度疼痛无差异,CO2组腺瘤检出率15%高于WAS组11%,但两组均高于国家最低性能标准,两种技术成本差异可忽略。

要点

  • WAS组与CO2组患者报告中重度疼痛分别为14%与15%,无统计学差异(p=0.47)。
  • CO2组腺瘤检出率15%高于WAS组11%(p=0.03),但两组均高于国家最低性能标准。
  • 两组平均腺瘤数目及总体息肉检出率无统计学差异,成本差异可忽略。

核心结论

  • 在采用灌肠准备、非镇静、由筛查认证内镜医师操作的筛查性乙状结肠镜检查中,使用CO2或WAS插管技术,患者报告的疼痛无差异。

研究设计与样本

  • WASh试验为多中心、单盲、随机对照试验,纳入接受肠道筛查乙状结肠镜检查(BSS)的人群,从英格兰五个中心随机分配至WAS组或CO2组。
  • 共1123名参与者被随机分组(WAS组561人,CO2组562人),女性占50%,平均年龄55岁。
  • 主要结局为患者出院前采用标准Likert量表报告的中重度疼痛;关键次要结局为腺瘤检出率(ADR);同时测量每种技术的成本。

主要发现

  • WAS组与CO2组患者报告中重度疼痛分别为14%与15%(p=0.47),无差异。
  • CO2组腺瘤检出率为15%,WAS组为11%(p=0.03);但两组均高于国家最低性能标准。
  • 两组平均腺瘤数目及总体息肉检出率无统计学差异。
  • 两种技术之间的成本差异可忽略。

关键数值与推荐

  • 主要结局:患者报告中重度疼痛WAS组14% vs CO2组15%(p=0.47)。
  • 关键次要结局:腺瘤检出率CO2组15% vs WAS组11%(p=0.03)。
  • 两组平均腺瘤数目及总体息肉检出率无统计学差异;成本差异可忽略。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The English Bowel Cancer Screening Programme invites 55 year olds for a sigmoidoscopy (Bowel Scope Screening (BSS)), aiming to resect premalignant polyps, thus reducing cancer incidence. A national patient survey indicated higher procedural pain than anticipated, potentially impacting on screening compliance and effectiveness. We aimed to assess whether water-assisted sigmoidoscopy (WAS), as opposed to standard CO2 technique, improved procedural pain and detection of adenomatous polyps. DESIGN: The WASh (Water-Assisted Sigmoidoscopy) trial was a multicentre, single-blind, randomised control trial for people undergoing BSS. Participants were randomised to either receive WAS or CO2 from five sites across England. The primary outcome measure was patient-reported moderate/severe pain, as assessed by patients on a standard Likert scale post procedure prior to discharge. The key secondary outcome was adenoma detection rate (ADR). The costs of each technique were also measured. RESULTS: 1123 participants (50% women, mean age 55) were randomised (561 WAS, 562 CO2). We found no difference in patient-reported moderate/severe pain between WAS and CO2 (14% in WAS, 15% in CO2; p=0.47). ADR was 15% in the CO2 arm and 11% in the WAS arm (p=0.03); however, it remained above the minimum national performance standard in both arms. There was no statistical difference in mean number of adenomas nor overall polyp detection rate. There was negligible cost difference between the two techniques. CONCLUSION: In the context of enema-prepared unsedated screening sigmoidoscopies performed by screening-accredited endoscopists, no difference in patient-reported pain was seen when using either a CO2 or WAS intubation technique. TRIAL REGISTRATION NUMBER: ISRCTN81466870.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Rutter MD, Evans R, Hoare Z, et al. WASh multicentre randomised controlled trial: water-assisted sigmoidoscopy in English NHS bowel scope screening. Gut. 2020. PMID: 32895334. doi:10.1136/gutjnl-2020-321918

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。